The Radionuclide Therapy Ward (Ward 75) of the Clinical Department of Nuclear Medicine at MHH is a special ward with 10 beds for targeted molecular treatment with open radioactive substances.
Following extensive renovation between 2011 and 2013, the ward is designed to provide the best possible care for patients with thyroid and tumor diseases.
Patients receive comprehensive care from a closely cooperating, well-coordinated team of physicians, nurses, technical assistants and physicists.
State-of-the-art measurement technology is available for precise diagnostics and gentle treatment (computer-aided probes, high-resolution ultrasound, rapid whole-body diagnostics, SPECT-CT hybrid imaging, PET-CT).
The ward is also connected to an ultra-modern waste disposal area with a residue store and biological decay system. Due to the extensive radiation protection, high-dose therapies can be carried out without restriction if required.
The modern equipment also includes
- TV, telephone and WLAN reception throughout the ward
- barrier-free, handicapped accessible bathrooms